These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 5522140)

  • 21. The new clearance method for hepatic diagnostics.
    Tichý JA; Loucka M; Trefný ZM
    Prague Med Rep; 2005; 106(3):229-42. PubMed ID: 16463581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indocyanine Green test and its development.
    Namihisa T
    Tokai J Exp Clin Med; 1982 Jul; 7(4):419-23. PubMed ID: 7179313
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the action of C-reactive proteins in relation to current liver tests].
    Renger F; Kanehl R; Kanehl E
    Acta Hepatosplenol; 1965; 12(6):337-51. PubMed ID: 5868476
    [No Abstract]   [Full Text] [Related]  

  • 24. [Liver function test after nicotinic acid loading. I. A clinical study].
    Finck C; Jorke D
    Acta Hepatosplenol; 1968; 15(5):315-21. PubMed ID: 5707324
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE VALUE OF FRACTIONAL CLEARANCE OF BSP IN THE DIAGNOSIS OF CHRONIC HEPATOPATHIES].
    NICOLAESCU T; FELBERG B; RUSOVICI L
    Med Interna (Bucur); 1964 Aug; 16():959-67. PubMed ID: 14192603
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the liver function with the aid of bromsulphalein and vofaverdin].
    Geller LI; Bulgakova OS; Griaznova MV; Ozherel'eva NIa
    Vrach Delo; 1978 Jun; (6):78-81. PubMed ID: 695480
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic processes in liver diseases with special reference to LE and pseudo-LE cell phenomena].
    Keitel W; Jürgensen UJ
    Z Gesamte Inn Med; 1967 Nov; 22(21):669-73. PubMed ID: 4174750
    [No Abstract]   [Full Text] [Related]  

  • 29. [Classification of dye excretion by the liver].
    Mikulecký M
    Bratisl Lek Listy; 1969; 52(3):315-27. PubMed ID: 5345612
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of ion-exchange chromatography of amino acids in acute and chronic liver diseases].
    Mironova IS; Semendiaeva ME; Spektor EB
    Sov Med; 1973 Jun; 36(6):111-5. PubMed ID: 4747408
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the significance of BSF clearance in chronic post-hepatitis liver diseases].
    Camilloni R; Ghinelli F; Pizzaferri A; Pizzigoni G; Fiaccadori F
    G Clin Med; 1972 Jul; 53(7):327-33. PubMed ID: 4666410
    [No Abstract]   [Full Text] [Related]  

  • 32. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detailed study of the kinetics of plasma bromsulphthalein. New experimental findings and theoretical considerations.
    Mikulecký M
    Clin Chim Acta; 1968 Jul; 21(1):43-8. PubMed ID: 5658954
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver clearance of bromosulphalein (BSF) in cirrhosis].
    Rodés J; Bordas JM; Bruguera M; Terés J
    Rev Clin Esp; 1968 Nov; 111(3):303-14. PubMed ID: 5736056
    [No Abstract]   [Full Text] [Related]  

  • 35. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.
    SCHOENFIELD LJ; FOULK WT; BUTT HR
    J Clin Invest; 1964 Jul; 43(7):1409-18. PubMed ID: 14192521
    [No Abstract]   [Full Text] [Related]  

  • 36. [131I-BSP kinetics in the liver and its application for various liver diseases (author's transl)].
    Nishimura T; Suematsu T; Hori M; Kimura K
    Rinsho Byori; 1977 Jul; 25(7):582-6. PubMed ID: 916245
    [No Abstract]   [Full Text] [Related]  

  • 37. The discrepancy between plasma clearance tests of indocyanine green (ICG) and sulfobromophthalein (BSP): --report of cases and a study of ICG-binding pattern of serum proteins.
    Adachi Y; Yamamoto T; Onishi S; Tanaka S; Wakisaka G
    Gastroenterol Jpn; 1976; 11(2):75-87. PubMed ID: 976692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competition by unconjugated and conjugated sulfobromophthalein sodium (BSP) for transport into bile. Evidence for a single excretory system.
    Whelan G; Combes B
    J Lab Clin Med; 1971 Aug; 78(2):230-44. PubMed ID: 5567563
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum free amino acid concentrations in liver diseases].
    Triapyshko AD
    Ter Arkh; 1971 Apr; 43(4):66-70. PubMed ID: 5123443
    [No Abstract]   [Full Text] [Related]  

  • 40. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.